Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B
They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide carry the evidence: STEP for semaglutide (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024)
When brands formulate copper peptide serums, they often position them as products that help support the appearance of well-maintained skin over time
Lipotropic injections produce best results as part of a comprehensive protocol, not in isolation
the liquid-phase synthesis method has the characteristics of simple operation and fast synthesis speed